A detailed history of Financial Partners Group, Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Financial Partners Group, Inc holds 1,023 shares of LLY stock, worth $765,214. This represents 0.14% of its overall portfolio holdings.

Number of Shares
1,023
Previous 975 4.92%
Holding current value
$765,214
Previous $882,000 2.72%
% of portfolio
0.14%
Previous 0.14%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$772.14 - $960.02 $37,062 - $46,080
48 Added 4.92%
1,023 $906,000
Q2 2024

Jul 19, 2024

SELL
$724.87 - $909.04 $10,148 - $12,726
-14 Reduced 1.42%
975 $882,000
Q1 2024

May 07, 2024

SELL
$592.2 - $792.28 $45,007 - $60,213
-76 Reduced 7.14%
989 $769,000
Q4 2023

Feb 09, 2024

SELL
$525.19 - $619.13 $7,352 - $8,667
-14 Reduced 1.3%
1,065 $620,000
Q3 2023

Nov 13, 2023

SELL
$434.7 - $599.3 $17,388 - $23,972
-40 Reduced 3.57%
1,079 $579,000
Q2 2023

Aug 08, 2023

SELL
$350.74 - $468.98 $23,850 - $31,890
-68 Reduced 5.73%
1,119 $524,000
Q1 2023

May 12, 2023

BUY
$310.63 - $364.82 $3,106 - $3,648
10 Added 0.85%
1,187 $407,000
Q4 2022

Feb 14, 2023

SELL
$321.55 - $374.67 $43,730 - $50,955
-136 Reduced 10.36%
1,177 $430,000
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $15,416 - $17,569
52 Added 4.12%
1,313 $425,000
Q2 2022

Aug 12, 2022

BUY
$278.73 - $327.27 $557 - $654
2 Added 0.16%
1,261 $409,000
Q1 2022

Apr 29, 2022

BUY
$234.69 - $291.66 $9,152 - $11,374
39 Added 3.2%
1,259 $361,000
Q4 2021

Feb 10, 2022

BUY
$224.85 - $279.04 $49,242 - $61,109
219 Added 21.88%
1,220 $299,000
Q3 2021

Nov 05, 2021

BUY
$221.6 - $272.71 $221 - $272
1 Added 0.1%
1,001 $231,000
Q2 2021

Aug 13, 2021

BUY
$180.55 - $233.54 $180,550 - $233,540
1,000 New
1,000 $229,000
Q1 2021

May 04, 2021

SELL
$164.32 - $212.72 $163,662 - $211,869
-996 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$130.46 - $172.63 $129,938 - $171,939
996 New
996 $202,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Financial Partners Group, Inc Portfolio

Follow Financial Partners Group, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Partners Group, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Financial Partners Group, Inc with notifications on news.